Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site: HC II Tokushima

Thrombosis and Haemostasis

Volumn 85, Issue 1, 2001, Pages 101-107

  Kanagawa, Y ^a   Shigekiyo, T ^a   Aihara, K I ^a   Akaike, M ^a   Azuma, H ^a   Matsumoto, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Chaperone; Heparin cofactor II; Thrombin; Thrombosis; Transfection

Indexed keywords

CHAPERONE; HEPARIN COFACTOR II; LEUCINE; PROLINE; THROMBIN;

AGED; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING FACTOR DEFICIENCY; CASE REPORT; CELL STRAIN COS1; CHO CELL; CODON; FEMALE; GENE AMPLIFICATION; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; MISSENSE MUTATION; MOLECULAR GENETICS; NONHUMAN; NORTHERN BLOTTING; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK FACTOR; THROMBOSIS;

EID: 0035171975     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612911     Document Type: Article

References (37)

1. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma
2. A new member of the plasma protease inhibitor gene family
3. Heparin cofactor II: cDNA sequence, chromosome localization, restriction length polymorphism, and expression in Escherichia coli
4. Insight into the mechanism of action of heparin cofactor II
5. The protease specificity of heparin cofactor II: Inhibition of thrombin generated during coagulation
6. Inhibition of chymotrypsin by heparin cofactor II
7. Activation of heparin cofactor II by dermatan sulfate
8. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells
9. Constitutional heparin cofactor II deficiency associated with recurrent thrombosis
10. Association of hereditary heparin cofactor II deficiency with thrombosis
11. Hereditary heparin cofactor II deficiency and thrombosis: Report of six patients belonging to two separate kindreds
12. Recurrent venous thrombosis associated with inherited deficiency of heparin cofactor II
13. Heparin cofactor II Oslo: Mutation of Arg- 189 to His decreases the affinity for dermatan sulfate
14. Hereditary heparin cofactor II deficiency and coronary artery disease
15. Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan
16. A heparin cofactor II mutation (HC II Rimini) combined with factor V Leiden or type I Protein C deficiency in two unrelated thrombophilic subjects
17. Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis
18. Molecular and cellular basis for type I heparin cofactor II deficiency (Heparin cofactor II Awaji)
19. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis
20. Congenital plasminogen deficiency caused by a Ser 572 to Pro mutation
21. Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11
22. A rapid alkaline extraction procedure for screening recombinant plasmid DNA
23. Structure and expression of the gene coding for the human serpin hLS2
24. Antithrombin Mutation Database: 2nd (1997) Update
25. Folding of secretory and membrane protein
26. Murine heparin cofactor II: Purification, cDNA sequence, expression, and gene structure
27. Secondary thrombin-binding site, glycosaminoglycan binding domain and reactive center region of leuserpin-2 are strongly conserved in mammalian species
28. Molecular cloning and expression of rabbit heparin cofactor II: A plasma thrombin inhibitor highly conserved between species
29. Isolation of frog and chicken cDNA encoding heparin cofactor II
30. 1-antitrypsin for structure and function of serpins
31. Antithrombin III Stockholm: A codon 392 (Gly to Asp) mutation with normal heparin binding and impaired serine protease reactivity
32. Characterization of a functional thrombin receptor. Issues and opportunities
33. The pathogenesis of atherosclerosis - An update
34. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery
35. Thrombin receptor expression in normal and atherosclerotic human arteries
36. Effects of fibroblasts and endothelial cells on inactivation of target proteases by protease nexin-1, heparin cofactor II and C1-inhibitor
37. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries